The 18th annual international congress of the World Muscle Society was held October 1-5 in California. Researchers from Nationwide Children’s Hospital and collaborating labs at The Ohio State University were particularly well represented among the more than 550 attendees, and several received special recognition:
Federica Montanaro, PhD (Investigator, Center for Gene Therapy) received one of the only four Elsevier Prizes for outstanding presentation for her oral presentation, “Identification of novel dystroglycan-associated glycoprotein complexes in skeletal muscle.”
Nicolas Wein, PhD (Postdoctoral fellow, Flanigan lab, Center for Gene Therapy) received the award for the Best Contribution by a Young Researcher on Treatment of Duchenne Muscular Dystrophy for his oral presentation, “Using out-of-frame exon skipping to induce IRES-driven expression of an N-truncated dystrophin isoform for 5’ DMD mutations."
Adeline Vulin-Chaffiol, PhD (Postdoctoral fellow, Flanigan lab, Center for Gene Therapy) received an Elsevier subscription prize for outstanding posters for her presentation, “Restoration of dystrophin expression after skipping of single and double exon DMD duplications in patient-derived cell lines using antisense oligonucleotide and AAV-U7snRNA approaches.”
Lindsay Wallace, PhD (Postdoctoral fellow, Harper lab, Center for Gene Therapy) received an Elsevier subscription prize for outstanding posters for her presentation, “The DUX4 promoter is expressed in FSHD-affected tissues.”
Paul Martin, PhD (Investigator, Center for Gene Therapy) gave an invited keynote presentation entitled “Progress in gene therapy for muscular dystrophy using vascular delivery of GALGT2.”